Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotate
2013
Purpose
The aim of this study was to explore the possible mechanisms involved in an observed decline in serum calcium levels in patients with a neuroendocrine tumour (NET) treated with [177Lu-DOTA0,Tyr3]octreotate (177Lu-octreotate).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
16
References
4
Citations
NaN
KQI